Effect of Branched-chain Amino Acid Supplementation on Muscle Damage

Status Recruiting

Clinical Trial Summary

Seventy-eight recreational athletes who never resistance trained will be randomly assigned into three groups of twenty-six. Branched-chain amino acid will be supplemented for 18days at 0, 200 or 400 mg/body weight(kg)/day in jelly. Participants will be asked to perform elbow flexions on the 12th day of supplementation. Maximum voluntary contractions will be measured before, during and after the supplementation period to compare the effects of different doses of branched-chain amino acid has on muscle damage markers.

Clinical Trial Description

Previous studies have not been able to show consistent effects due to various reasons. The major limitations are the lack of enough data on the amount and duration of branched-chain amino acid supplementation, and the level of muscle damage for branched-chain amino acid to be effective. Based on a recent meta-analysis, it has been suggested that to be effective, branched-chain amino acid should be supplemented more than 200mg/kg/day before a low-to-moderate intensity exercise bout. Therefore, this study is designed based on the above suggestions and to compare the effect of different doses of branched-chain amino acid on muscle damage markers in healthy recreational active individuals.

Three treatment groups (n=26) will be randomly assigned to be supplemented with either 200mg BCAA/kg/day (BCAA200), 400mg BCAA/kg/day (BCAA400) or placebo (fiber supplement; PL). Supplements will be provided in jelly in a single blind fashion to be ingested 1hour after each of the three main daily meals for 18days. Anthropometric measurements (body weight, lean mass, height), body temperature, ultrasound (US), strength assessment (maximal voluntary contraction, MVC), resting metabolic rate (RMR), rate of perceived exertion (RPE), delayed onset of muscle soreness (DOMS) and blood samples (duplicates; myoglobin; BCAA) will be collected before, during and after the supplementation period at different time points (see appendix for the above tables). Repeated-bout effect (RBE) on both arms will be measured 7 days after the damage inducing session. ;

Study Design

Related Conditions & MeSH terms

Muscle Damage

Clinical Trial Details

NCT number	NCT03766815
Study type	Interventional
Source	Western University, Canada
Contact	Crystal Lee, BSc
Phone	519 6612111
Email	plee263@uwo.ca
Status	Recruiting
Phase	N/A
Start date	October 1, 2019
Completion date	December 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04136821` - The Long-term Effects of Oceanix™ on Resistance Training Adaptations	N/A
Completed	`NCT03318731` - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males	N/A
Unknown status	`NCT02280668` - Investigating Muscle Repair in Response to Icing Therapy Post Eccentric Muscle Damage Exercise	N/A
Completed	`NCT04315077` - The Short Term Effects of Oceanix Supplementation on Recovery	N/A
Completed	`NCT03313388` - Tart Cherry Juice for Exercise Performance and Recovery	N/A
Completed	`NCT03753321` - Whey and Soy Protein Supplementation in Football Players	N/A
Recruiting	`NCT06334224` - Acute Physiological Responses to Twice Daily Blood Flow Restriction Training	N/A
Recruiting	`NCT03707067` - Compression Garments for Recovery in Modern Pentathletes	N/A
Completed	`NCT03707470` - Made to Measure Compression Garments for Recovery in Rugby Players	N/A
Completed	`NCT05037942` - The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise	N/A
Completed	`NCT05100459` - The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals	N/A
Recruiting	`NCT04549610` - HMB and Exercise-induced Muscle Damage	Phase 2/Phase 3
Completed	`NCT05804604` - Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
Completed	`NCT05011643` - Exercise-induced Muscle Damage in Statin Users
Completed	`NCT01827696` - Effect of American Ginseng on Exercise-induced Muscle Soreness	Phase 1
Completed	`NCT01728675` - Eccentric Exercise and Oxidative Stress	N/A
Completed	`NCT03527797` - Diaphragm Protective Ventilation in the Intensive Care Unit	N/A
Withdrawn	`NCT05044936` - Topical Cannabidiol Cream and Post-exercise Recovery	Early Phase 1
Completed	`NCT04679519` - The Effects of Protein Supplementation in Females and Males Following Acute Eccentric Exercise	N/A
Completed	`NCT01555775` - Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Recovery After Resistance Exercise	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.